- Home
- LITE vs GH Comparison
LITE vs GH Comparison
Compare LITE & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITE
- GH
- Stock Information
- Founded
- LITE 2015
- GH 2011
- Country
- LITE United States
- GH United States
- Employees
- LITE N/A
- GH N/A
- Industry
- LITE Telecommunications Equipment
- GH Medical Specialities
- Sector
- LITE Telecommunications
- GH Health Care
- Exchange
- LITE Nasdaq
- GH Nasdaq
- Market Cap
- LITE 5.7B
- GH 4.9B
- IPO Year
- LITE N/A
- GH 2018
- Fundamental
- Price
- LITE $89.66
- GH $49.14
- Analyst Decision
- LITE Buy
- GH Strong Buy
- Analyst Count
- LITE 15
- GH 20
- Target Price
- LITE $82.47
- GH $54.35
- AVG Volume (30 Days)
- LITE 2.0M
- GH 2.2M
- Earning Date
- LITE 08-13-2025
- GH 08-06-2025
- Dividend Yield
- LITE N/A
- GH N/A
- EPS Growth
- LITE N/A
- GH N/A
- EPS
- LITE N/A
- GH N/A
- Revenue
- LITE $1,472,600,000.00
- GH $773,996,000.00
- Revenue This Year
- LITE $21.98
- GH $23.14
- Revenue Next Year
- LITE $31.42
- GH $21.42
- P/E Ratio
- LITE N/A
- GH N/A
- Revenue Growth
- LITE 3.58
- GH 28.20
- 52 Week Low
- LITE $38.29
- GH $20.14
- 52 Week High
- LITE $104.00
- GH $52.92
- Technical
- Relative Strength Index (RSI)
- LITE 73.20
- GH 62.17
- Support Level
- LITE $81.93
- GH $48.00
- Resistance Level
- LITE $88.21
- GH $51.71
- Average True Range (ATR)
- LITE 3.56
- GH 2.67
- MACD
- LITE 0.38
- GH 0.39
- Stochastic Oscillator
- LITE 94.61
- GH 78.60
About LITE Lumentum Holdings Inc.
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.